Call for Abstract

16th International Conference on Pharmaceutics and Drug Safety, will be organized around the theme “Drug safety Management {CME-CPD Accreditations Available} ”

Drug Safety 2023 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Drug Safety 2023

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The term "pharmaceutical analysis" refers to the study of drugs, both as bulk drug molecules and as pharmaceutical products (formulations).Pharmaceutical Quality Assurance is essential to ensuring that medicines are produced and dispensed in a consistent, secure manner. This is essential to make sure that no one becomes ill or experiences an aggravation of their symptoms as a result of taking the medication. Research, development, manufacturing, and distribution are just a few of the many facets of pharmaceutical quality assurance (PQA) that potentially compromise the integrity of medical products. To continue to be lawful, medications must maintain a high level of quality. The reputation and standards of the companies they work for must also be upheld.

  • Quality Assurance and Control
  • Pharmaceutical quality assurance
  • Purpose of Pharmaceutical Analysis and Quality Assurance

Any substance made from living things or containing elements of live things is referred to as a biologic medicine (biologic). Pharmaceuticals derived from humans, animals, or microorganisms under the general heading of "biologic drugs" are produced using biotechnology. Biologic drugs include, among other things, vaccines, blood and blood components, cells, allergies, genes, tissues, and recombinant proteins.

A jack-of-all-trades in the medical field, biomolecules are capable of doing everything. Asthma and multiple sclerosis can both be treated with them, and immunizations against the flu and polio can assist the body's own immunological defences by boosting them. They can also be used to diagnose and treat malignant disorders. In the pharmaceutical industry, new biomolecules are continuously being created: Specific antibodies, customised proteins, and nucleic acids — the basic building blocks of genetic material — are all viewed as potential therapeutic candidates.

Drug therapy products with an active ingredient obtained from a biological source are referred to as biotherapeutics, often known as biologicals. Nearly half of all new drugs approved in recent years have been biotherapeutics, a market section of the pharmaceutical industry that is expanding quickly.

  • Patient Education for Biotherapy and Chemotherapy
  • Utilized Biological Response Modifiers
  • Treatment of Wounds Using Biotherapy
  • Nuclear medicine uses radiopharmaceuticals
  • Radiopharmaceutical diagnostics

Pharmaceutical microbiology is the term used to describe the application of microbiology in pharmaceutical and healthcare situations. It is a subfield of microbiology that acknowledges the tremendous diversity of microorganisms in the environment, which has a wide range of potential outcomes, some of which are advantageous and others which are destructive. It emphasises the importance of a variety of microbes and toxins (microbial byproducts like endotoxins and pyrogens) in pharmaceutical raw materials, finished products, intermediates, and pharmaceutical manufacturing environments, as well as microbiological control of pharmaceutical products and manufacturing environments.

Pharmaceutical biotechnology, which applies biotechnology ideas to drug discovery, is a vibrant and expanding field. Pharmaceutical biotechnology, which applies biotechnology ideas to drug discovery, is a vibrant and expanding field. Utilizing monoclonal antibodies or recombinant DNA technology, which involves the genetic modification of cells, the pharmaceutical biotechnology sector produces biotechnological goods.

  • preventing the deterioration of pharmaceuticals
  • Environments under control for RDT in drug development
  • bacterial resistance
  • Microbiology
  • biological molecular
  • Biochemistry
  • Genetics

Effective medications target tumours, tissue damage, or low-toxic medications at the infection site. Targeted medicine distribution has become more important in the treatment of many illness situations because it increases the pharmacological effects of pharmaceuticals and reduces their negative side effects. Few targeted drug delivery systems can achieve high targeting efficiency after intravenous injection, despite the discovery of several surface indicators and targeting strategies. Cell-mediated drug-delivery targeting systems have drawn a lot of attention due to their enhanced therapeutic specificity and effectiveness in the treatment of the disease. Cell-based drug delivery systems have a wide range of potential biological uses, providing new insights into the therapeutic potential of our cells. Different therapy approaches can be made significantly more effective by intracellular administration of various medications, including DNA and drug carriers.

  •  Nano-based medication delivery system
  • Designing and Targeting Drugs
  • System for Delivering a Specific Drug

For the treatment of respiratory conditions like asthma and chronic obstructive pulmonary disease, inhalation therapy is frequently employed. Compared to other methods of administration, inhalation provides a number of benefits in the treatment of various illnesses. In recent decades, inhalation therapy has become more and more common. The most recommended way to administer drugs used to treat respiratory conditions like asthma and chronic obstructive lung disease is currently through inhalation (COPD). The route of inhalation for systemic pharmaceutical administration is also being researched in specific circumstances. Inhalation therapy for local treatment primarily aims to alleviate and/or prevent pulmonary symptoms, such as airway irritation and tightness.

  • The demand for inhaled medication delivery
  • Nebulized treatment innovation
  • Modern advancements in nebulizers
  • Development of MDIs without propellants
  • Medication distribution through aerosols
  • The difficulties with triple-combination inhalers
  • Imaging of the breathing function

Present-day pharmaceutical product development and manufacture involves a series of scale-ups, starting with small amounts of material for preliminary safety or clinical studies and moving on to a manufacturing facility to offer commercial supply. The production of pharmaceutical drugs is the focus of the pharmaceutical manufacturing sector of the industry. Product development is different in the pharmaceutical sector from other industries. Because the science and engineering of pharmaceutical product development is not as advanced as, say, that of the chemical industry, it is essentially empirical, laborious, and time and resource intensive. This is the main reason why the pharmaceutical manufacturing business is still behind, despite the billions of dollars that have been invested in production by the pharmaceutical industry.

  • Technology and tools for manufacturing
  • Modern manufacturing processes
  • Pharmacy, both commercial and physical
  • Technology in Pharmaceuticals
  • Pharmaceutical Containers


Vaccines are substances that are given to patients to elicit immunological reactions that lead to the production of antibodies (humoral) or cell-mediated responses that will aid them in fighting infectious pathogens or non-infectious illnesses like cancer. Immunology, protein design, and genetic delivery advancements have created previously unthinkable opportunities for vaccination concepts and delivery methods. Since they have the potential to provide answers to challenging targets where conventional approaches have failed, these next-generation vaccine design attempts are very intriguing. Because they do away with the need for booster doses and give long-term therapy in manageable dosages, vaccine medication delivery systems have been proved to be patient-friendly. Their use is further encouraged by the development of needle-free administration methods.

  • IImmunotherapy and vaccinations
  • New Drug Delivery Systems for Vaccines


A protein is a large molecule made composed of one or more amino acids arranged in a certain order. Drugs are delivered to their target locations of action with the help of proteins and peptides. Over the past twenty years, researchers have focused on a wide range of biopharmaceutical process development domains. The majority of therapeutic proteins have been studied, and issues with cell culture, purification, recovery, and fermentation have all been solved. Mass synthesis of a number of chemicals allowed for their widespread application in medical therapy thanks to the quick development of biotechnology and developments in peptide and protein chemistry. Although not always, proteins and peptides play a significant role as regulators in biological processes.

  • Development of Peptide Formulas

The process of finding chemical compounds that have the potential to be therapeutic agents is referred to as drug discovery. Drug development refers to all processes that take a chemical from drug candidate (the result of the discovery phase) to a finished good that has been given the go-ahead for commercialization by the appropriate regulatory bodies. A major objective of drug development programmes is the discovery of novel molecular entities that might be helpful in the treatment of disorders that fall under the category of unmet medical needs.

Prior to choosing a candidate drug for clinical trials, the process of drug screening involves locating and improving promising pharmaceuticals. To assess the potential of biological extracts or molecules, bioactive compound screening uses a wide variety of analytical techniques. The tests may be carried out on the entire animal, in individual cells, or at the molecular level. Reverse pharmacology, also known as target-based drug discovery, and classic pharmacology, commonly referred to as phenotypic drug discovery, are two complementing methods for finding new drugs. Phenotypic drug discovery is the historical foundation of drug discovery.

  • Models for Drug Screening in Vitro
  • medication design based on structure
  • High-Throughput Screening (HTS) 

The pharmaceutical science pertaining to the "gathering, identification, assessment, monitoring, and prevention" of adverse effects with pharmaceutical goods is known as pharmacovigilance, commonly referred to as drug safety. The words "pharmacovigilance" and "pharmakon," both from the Greek for "drug," have similar etymological roots (Latin for to keep watch). As a result, pharmacovigilance places a lot of emphasis on adverse drug reactions (ADR), which are described as any noxious and unintended response to a drug, such as a lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation). Even in the absence of an adverse event, medication errors such as overdosing, drug addiction, misuse, and exposure to drugs while pregnant or nursing are of importance since they may result in a negative pharmacological reaction.

Regulatory affairs is a field that keeps an eye on how foods, medications, and medical devices are created, tested, produced, marketed, and distributed to make sure they adhere to regulations for human consumption. Experts in regulatory affairs are in charge of making sure manufacturers follow all applicable laws and regulations at every stage of product development. Regulatory affairs are understood in a very specific way in the healthcare sector. Pharmaceuticals that are high-quality, safe, and effective are produced and distributed in accordance with its regulations. With the adoption of new rules and technological advancements, pharmaceutical formulation must now contend with new objectives and challenges.

Regulations, guidelines, and technologies

  • GMP
  • CGMP

Recent years have seen the introduction of intelligent drug delivery systems that can immediately detect and react to pathophysiological situations, as well as a number of proteinic and other medications intended to target various cellular processes. Traditional small molecules and modern large molecules are typically administered without a precise molecular-targeting strategy or targeted at cell surface targets; these potential innovative medicines are different. To maximise their potential patient benefits, novel chemicals must be released in tissues and cells in a targeted and controlled manner, which calls for sophisticated drug delivery systems. The phrase "advanced drug delivery system" describes a method that boosts drug potency, controls drug release for a more protracted therapeutic effect, and raises safety levels before finally directing a drug to the right tissue.

  • New Technologies for Drug Delivery
  • Drug Delivery System for Implants
  • Child-friendly drug delivery methods
  • Routes for administering drugs

Novel Drug Delivery Systems are techniques, formulations, technologies, and systems for safely delivering pharmaceutical drugs to their intended therapeutic effects within the body (NDDS). Drug delivery systems offer a lot of promise to enhance the therapeutic and diagnostic effects of medications because of their special characteristics. In contrast to other drug administration technologies, NDDS is a drug delivery mechanism. Innovative dosage forms that are vastly superior to conventional dosage forms are combined with cutting-edge technology. The Novel Drug Delivery System has a number of advantages, including the following: the ideal dosage at the ideal time and location, Excipients, production expenditures, and expensive drugs are all used more effectively. Patients gain from better therapies, higher standards, and greater quality of life.

  • Nanoencapsulation and nanodrugs
  • Controlled Drug Delivery System
  • Ocular Drug Delivery System
  • 2D & 3D Printing in Drug Delivery
  • Targeted Drug Delivery System
  • Controlled Drug Delivery System
  • Modulated Drug Delivery System
  • Drug Delivery: Devices and Equipment

The potential for using nanoparticles as a drug delivery system is enormous. Nano systems with different compositions and biological characteristics have been extensively researched for use in drug delivery and gene delivery applications. Nanoscale materials are employed as diagnostic instruments or to deliver therapeutic medications to specific sites in a controlled manner in the field of nanomedicine and nano delivery systems, which is still relatively young but is swiftly expanding. Nano-drug delivery systems (NDDSs) are a class of nanomaterial that can prolong cycle duration, boost target cell or tissue absorption rate, reduce enzyme degradation, and improve drug stability and water solubility while also enhancing medication safety and effectiveness.

  • Nanoparticles: New Developments and Trends
  • Biomedical and Nanotechnology Applications
  • Systematic Drug Delivery Using Nanoparticulates
  • Non-Coding RNA Nanoparticle Delivery
  • Fabrication of Nanoparticles
  • How Big Data Can Aid Nanotechnology
  • Nanotechnology Clinical Translation
  • Nanoparticles for Screening and Immuno-Oncology

Pharmacogenomics is an example of precision medicine, which aims to tailor medical treatment to each person or group of people. Pharmacogenomics is the study of how your DNA affects how you react to medications. Pharmacogenomics is the scientific study of how medications affect inherited genes. This includes how inherited genes affect how different people's bodies respond to different medications. Pharmacogenomics has many applications, including the correlation of individual genetic variation with pharmaceutical responses. Pharmacogenomics is one of the most significant components of personalised medicine.

  • Biology & Genetic Engineering
  • Genomic and Pharmacogenetic Research
  • Metabolism of drugs


Although commonly confused with pharmacy, pharmacology is a distinct field of study in the health sciences. Pharmacology is the study of how a medicine interacts with a biological system and the body. The study of medicines includes information on their chemical composition, biological effects, and therapeutic uses. These effects can be either therapeutic or harmful depending on a number of circumstances. Pharmacologists are frequently interested in two areas of study: toxicology, which examines the negative or toxic effects of medications and other chemical agents, and therapeutics, which focuses on how drugs and other chemical agents affect disease. Pharmacology includes a variety of disciplines, including those in medicine, pharmacy, nursing, dentistry, and veterinary medicine. Some of the most intriguing developments in modern medicine are being made at the cutting edge of pharmacology.

  • Neuropharmacology
  • Methods to modelling and computation
  • Pharmacology of regeneration
  • Individualized, exact medicine
  • PharmacokineticsPharmacodynamics
  • Pharmaceutical Science of the Heart

Preformulation is a set of studies that looks at the physicochemical properties of a potential drug candidate and how they might impact dosage form development and medication performance. This might be helpful for developing new products or proving the requirement of molecular modification. Preformulation research starts once the new chemical has been seeded. In a larger sense, it entails investigations into a molecule's physical, chemical, analytical, and medicinal properties as well as recommendations for altering the molecule to enhance its functionality. As a result, a preformulation research is a process for creating pharmaceutical formulations that applies and incorporates knowledge from the fields of toxicology, biochemistry, medicinal chemistry, and analytical chemistry.

  • Organoleptic and Bulk Characters
  • Examination of soluble compounds
  • Analysis of stability


The goal of biological or biologic therapy is to improve or restore the body's natural defence mechanism's capacity to fend against sickness and infection. A variety of malignancies and other disorders can be treated with biological therapy, sometimes referred to as biotherapy or immunotherapy. The use of biological response modifiers is common in biological therapy (BRMs). The body regularly produces these substances in trace levels as a defence against sickness and infection. With the use of contemporary laboratory methods, BRMs can be generated in vast quantities.

Biologically active substances known as radiopharmaceuticals are radionuclide-labeled to serve as a reliable source of ionising radiation for therapeutic and diagnostic reasons. Drugs called radiopharmaceuticals are used to identify and treat medical diseases. They may be given to the patient in a number of ways. For instance, they can be injected, injected intravenously, or placed in the bladder or eye.

  • Inhibitors of the tumour necrosis factor (TNF)
  • B-cell blockers
  • Inhibiters of interleukins (IL)
  • Modulators of selective co-stimulation
  • Precursors for radiopharmaceuticals and their preparation
  • Radionuclide producer

Research and development (R&D) is a crucial phase of drug development in the pharmaceutical (Pharma) sector. The research and development (R&D) of novel medications in the pharmaceutical sector. Some of the procedures include comprehending the illness and choosing a target—typically a cell's receptor site—that a therapeutic chemical can affect. R&D in the pharmaceutical industry is essential to policy because it justifies exorbitant costs and greater safeguards against normal price competition, which has historically been a source of innovation. The relationship between drug business costs, innovation rates, and prices has drawn public attention to pharmaceutical R&D. Pharmacy, both commercial and physical

  •  Chemical Biology in Pharmacology
  • Pharmacological Research Advances
  • Organic Pharmacy for Pharmaceuticals
  • Clinical Trials in Drug Delivery Systems and Clinical Research
  • RNA's new therapeutic pharmacological targets


No medication is completely safe, and all medications have the potential to cause negative effects. Pharmacovigilance is the process of identifying and responding to medication safety risks, and its use has grown over the past 10 to 15 years. Pharmacovigilance is a term used to describe the science and endeavours involved in the recognition, evaluation, comprehension, and avoidance of side effects or any other drug-related issue. Pharmacovigilance's main goal is to encourage the safe and efficient use of pharmaceuticals, particularly by providing timely information about their safety to patients, healthcare providers, and the general public. As a result, pharmacovigilance is an activity that supports patient safety and public health.

  • Adverse effects of drugs
  • Investigations of cases and clinical data

Pharmaceutical formulation, in pharmaceutics, is the process of mixing several chemical components, including the active medication, to produce a finished pharmacological product. The terms dose form and formulation are commonly used in the same sentence. Although finding novel therapies is becoming more difficult, a drug's efficacy can be increased while reducing side effects by changing the way it is delivered. This procedure is referred to as formulation discovery. Modern or conventional formulation technologies can be employed in formulation discovery. Creating a stable and patient-acceptable medication formulation is the goal of formulation studies.

  • Creation and Development of New Modalities via Analysis
  • Preservative and Excipient Issues
  •  New Excipients and Polysorbate Issues
  • New Lyophilization Developments and Alternative Drying Methods
  • Scalability, Robustness, and Developability


The brain is a very delicate and sensitive neuronal organ system that needs a constant supply of fuels, gases, and nutrients to maintain homeostasis and other important activities. Delivering drugs to the brain has been shown to be particularly difficult because of the blood-brain barrier (BBB). Only small molecules can pass through the BBB in a healthy brain, acting as a diffusion barrier to stop the majority of substances from entering the brain from the bloodstream. In the next 20 years, global drug development for brain diseases will need to significantly increase due to the rising numbers of seniors and patients with CNS issues. However, compared to other therapeutic areas, brain disease drug development has the lowest success rates.

  • Nanoparticle Delivery Throughout The BBB
  • Pharmacological Delivery to the Brain
  • In states of disease, the blood-brain barrier
  • BBB Models: New Approaches


Drug carriers are any materials used in the drug delivery process to increase the efficacy, safety, or selectivity of drug administration. Drug carriers are typically used to control a drug's absorption into the bloodstream. Systems created specifically for therapeutic drug delivery enable the precise and/or controlled release of pharmaceuticals. The treatment and potential cure of a variety of drug carrier systems are significantly impacted by many chronic diseases, including cancer. In the management of human diseases, nasal and pulmonary routes of drug administration are becoming more and more significant. These approaches present fascinating substitutes to parenteral medication administration, particularly for peptide and protein therapeutics. This can be accomplished by either releasing the medication slowly over time (often through diffusion) or by activating the release of the drug at the target site in response to an external stimulus, such as a pH change, the application of heat, or light activation.

  • Polymers in the Delivery of Drugs
  • Drug Delivery using Smart Materials
  • Transportation for drugs
  • Drug Delivery Using Biomaterials